Label Image (Lbl504360033)
Sildenafil
Product Images NDC 50436-0033
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50436-0033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Sildenafil 01)
Chemical Structure (Sildenafil 02)
Figure 2 (Sildenafil 03)
This appears to be a list of drug interactions with Atorvastatin and their associated recommendations for dosage adjustment. The drugs listed include Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir. The chart shows fold changes and 90% confidence intervals, as well as recommendations for dose adjustments for each drug. There is also a note about sildenafil and bosentan therapy not affecting exercise capacity.*
Figure 3 (Sildenafil 04)
This appears to be a list of drugs that interact with Acenocoumarol and could potentially impact International Normalized Ratio (INR) measurements. For each interacting drug, it indicates whether there is a recommended dose adjustment or not. The list includes Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, and Tolbutamide. There is also information provided on the fold change and 90% confidence interval, as well as the impact on INR AUC, INR Cmax, and bleeding time.*
Figure 4 (Sildenafil 05)
The text represents a table or graph showing the change in distance (in meters) from a baseline measurement at weeks 4 and 12 of a study evaluating the impact of different doses of sildenafil compared to placebo. The key indicates that the study tested three different doses of sildenafil (40mg, 80mg, and 20mg) and a placebo control.*
Figure 5 (Sildenafil 06)
This appears to be a medical document describing a medication called Sidenafil. The document includes information about the dosage of the medication. It also mentions a study or clinical trial related to the medication's impact on walking distance. Some additional information related to the study's findings and medical terminology is also provided but not clear due to missing characters.*
Figure 6 (Sildenafil 07)
Figure 7 (Sildenafil 08)
Greenstone Logo (Sildenafil 09)
This text is a brief description of the distributor of the Greenstone® brand, Greenstone LLC, located in Peapack, NJ 07977.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
